Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Agile Therapeutics Inc
(NQ:
AGRX
)
0.6022
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Agile Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Agile Therapeutics: Q4 Earnings Insights
Today 8:15 EDT
Via
Benzinga
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
Today 8:05 EDT
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics's Earnings: A Preview
March 27, 2024
Via
Benzinga
Why Agile Therapeutics (AGRX) Stock Is Down 60%
March 26, 2024
Agile Therapeutics shares are trading lower by 61% during Tuesday's session. The company announced the suspension of its trading on the Nasdaq effective Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 25, 2024
Via
Benzinga
Agile Therapeutics Announces Delisting from Nasdaq
March 25, 2024
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics's Earnings: A Preview
March 21, 2024
Via
Benzinga
Earnings Scheduled For March 22, 2024
March 22, 2024
Companies Reporting Before The Bell • Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share on revenue of $9.20 million.
Via
Benzinga
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
March 21, 2024
Live Conference Call and Webcast at 8:30 a.m. ET
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
March 20, 2024
Live Conference Call and Webcast at 8:30 a.m. ET
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 13, 2024
Via
Benzinga
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
March 13, 2024
Elimination of Remaining Debt to Perceptive Advisors Leaves the Company’s Balance Sheet Debt Free
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
What's Going On With Women Health Focused Agile Therapeutics Stock Today?
February 22, 2024
Agile Therapeutics stock rises on premarket trading, exercising warrants for $4.8M gross proceeds with reduced exercise price of $1.25 per share.
Via
Benzinga
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
February 22, 2024
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 22, 2024
Shares of Etsy, Inc.
Via
Benzinga
Why Is Bel Fuse (BELFB) Stock Down 17% Today?
February 22, 2024
Bel Fuse stock is falling on Thursday as investors in BELFB shares react to the company's lackluster Q4 2023 earnings report.
Via
InvestorPlace
Why Is Draganfly (DPRO) Stock Down 48% Today?
February 22, 2024
Draganfly stock is down on Thursday after the company announced details for a $3.6 million public offering of DPRO shares.
Via
InvestorPlace
Why Is BuzzFeed (BZFD) Stock Up 101% Today?
February 22, 2024
BuzzFeed stock is rising higher on Thursday as investors in BZFD react to it selling Complex for $108.6 million in cash.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 22, 2024
Via
Benzinga
Why Is Agile Therapeutics (AGRX) Stock Up 87% Today?
February 22, 2024
Agile Therapeutics stock is rising higher on Thursday with heavy trading of AGRX shares despite a lack of news from the company.
Via
InvestorPlace
Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
February 22, 2024
Shares of NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 22, 2024
Pre-market stock movers are a hot topic on Thursday and we're starting the day with a breakdown of all the latest news this morning!
Via
InvestorPlace
5 Value Stocks In The Healthcare Sector
February 19, 2024
Via
Benzinga
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
February 15, 2024
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
January 23, 2024
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
A Look Into Healthcare Sector Value Stocks
January 22, 2024
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
January 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 02, 2024
Via
Benzinga
Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage Requirement
December 12, 2023
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024
November 22, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.